Procaps S.A. has completed a private placement of senior notes
Procaps S.A. has raised funds to refinance existing debt with new institutional investors.
Procaps is a leading integrated international healthcare and pharmaceutical company that develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps has a product reach in 50 markets and has strategically positioned itself to achieve its M&A initiative and expand new product categories in the B2B and B2C segments.
Oaklins’ team in Chile acted as the sole financial advisor to Procaps S.A. in the private placement of senior unsecured fixed-rate notes for an aggregate principal amount of US$115 million.
Talk to the deal team
Boss Info has raised funds to support its growth strategy
Boss Info AG has raised equity and debt to support its growth strategy. While further capital measures are planned, the company’s founder, Simon Boss, will retain the majority of the shares.Learn more
IMD International Medical Devices has aised funds
IMD International Medical Devices has completed an IPO on the Euronext Growth Milan market, raising a total of US$6.5 million. The funds will be used to strengthen its competitive positioning in the market and implementing a growth strategy, both in Italy and abroad.Learn more
Azrieli Group Ltd. has issued bonds
Azrieli Group Ltd. has completed a fundraising to refinance and develop the company.Learn more